1. Home
  2. VSAT vs BMRN Comparison

VSAT vs BMRN Comparison

Compare VSAT & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$61.83

Market Cap

9.7B

Sector

Technology

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$58.62

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
BMRN
Founded
1986
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
10.4B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
VSAT
BMRN
Price
$61.83
$58.62
Analyst Decision
Strong Buy
Buy
Analyst Count
6
18
Target Price
$59.80
$88.22
AVG Volume (30 Days)
3.0M
2.1M
Earning Date
05-19-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
94.42
N/A
EPS
N/A
0.54
Revenue
N/A
$1,313,646,000.00
Revenue This Year
$5.32
$15.02
Revenue Next Year
$3.57
$12.23
P/E Ratio
N/A
$106.20
Revenue Growth
N/A
17.62
52 Week Low
$14.00
$49.26
52 Week High
$89.79
$66.28

Technical Indicators

Market Signals
Indicator
VSAT
BMRN
Relative Strength Index (RSI) 43.28 63.28
Support Level $58.84 $54.24
Resistance Level $64.98 $61.92
Average True Range (ATR) 5.43 1.42
MACD -0.91 0.23
Stochastic Oscillator 20.24 78.95

Price Performance

Historical Comparison
VSAT
BMRN

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: